Glimelife Glimepiride 2mg Blood Sugar Control Diabetes Tablets 30s

• Oral antidiabetic medicine containing glimepiride 2 mg • Second-generation sulfonylurea for type 2 diabetes mellitus • Stimulates insulin release from pancreatic beta cells • Once-daily dosing with meals • Film-coated tablets in packs of 30

Glimelife 2 mg Tablets contain glimepiride, a long-acting sulfonylurea that lowers blood glucose by stimulating insulin secretion and improving peripheral insulin sensitivity. It is indicated as monotherapy or in combination with metformin/insulin for type 2 diabetes when diet, exercise, and weight reduction fail. Glimepiride has a rapid onset and 24-hour duration, reducing postprandial and fasting glucose levels. It carries a lower risk of hypoglycemia than older sulfonylureas and is weight-neutral in most patients. Benefits • Effectively lowers HbA1c and fasting blood glucose • Once-daily dosing improves patient compliance • Rapid onset within 1–2 hours with sustained 24-hour control • Lower risk of severe hypoglycemia compared to glibenclamide • Can be combined with metformin or insulin for better control • Minimal weight gain and favorable cardiovascular profile • Cost-effective second-line therapy How to use • Starting dose: 1–2 mg once daily with breakfast or first main meal • Take with food to reduce gastrointestinal upset • Maximum dose: 8 mg daily (rarely needed) • Swallow whole with water; do not crush or chew • Monitor blood glucose regularly, especially when starting or adjusting dose • Risk of hypoglycemia increases with missed meals, alcohol, or exercise • Seek immediate medical help for symptoms of low blood sugar (sweating, shakiness, confus